NASDAQ: OSAProsomnus Inc Stock
$0.55-0.05 (-8.33%)
Updated Dec 8, 2023
OSA Price
$0.55
Fair Value Price
$721.20
Market Cap
$9.02M
52 Week Low
$0.35
52 Week High
$9.41
P/E
-0.39x
P/B
-0.27x
P/S
0.66x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.61M
Earnings
-$15.02M
Gross Margin
52.4%
Operating Margin
-34.05%
Profit Margin
-58.7%
Debt to Equity
-1.56
Operating Cash Flow
-$16M
Beta
-0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OSA Overview
Lakeshore Acquisition I Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets businesses in the financial services industry. Lakeshore Acquisition I was incorporated in 2021 and is headquartered in Shanghai, China.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OSA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OSA ($0.55) is undervalued by 99.92% relative to our estimate of its Fair Value price of $721.20 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OSA ($0.55) is significantly undervalued by 99.92% relative to our estimate of its Fair Value price of $721.20 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
OSA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OSA due diligence checks available for Premium users.
Be the first to know about important OSA news, forecast changes, insider trades & much more!
OSA News
Valuation
OSA fair value
Fair Value of OSA stock based on Discounted Cash Flow (DCF)
Price
$0.55
Fair Value
$721.20
Undervalued by
99.92%
OSA ($0.55) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OSA ($0.55) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OSA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OSA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.39x
Industry
34.17x
Market
31.32x
OSA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.27x
Industry
3.55x
OSA's financial health
Profit margin
Revenue
$7.1M
Net Income
-$11.2M
Profit Margin
-158.9%
OSA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OSA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$30.4M
Liabilities
$52.1M
Debt to equity
-1.56
OSA's short-term assets ($17.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OSA's long-term liabilities ($40.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OSA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OSA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.5M
Investing
-$691.4k
Financing
$9.1M
OSA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OSA vs Medical Device Stocks
Prosomnus Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.